Healthcare & Biotech Hedge Funds see asset surge 12%; Glenview Capital, OrbiMed & Visium lead gainers

August 13th, 2014
| More
The most recent Top 50 Healthcare, Pharmaceutical and Biotechnology Focused Hedge Fund list has been released, revealing that the top hedge funds now manage $78 billion in U.S. equity assets, having seen their asset jump by 12% year-to-date.

Leading the equity asset surge are Glenview Capital (+$1.9B), OrbiMed Advisrs (+$1.1B), Visium Asset Management (+$752M) and Partner Fund Management (+$650M). An impressive 76% of the hedge funds on the list have seen their equity assets increase year-to-date.

Larry Robbins’ Glenview Capital Management has retained the top spot, once again, with $15.1 billion in equity assets under management. Glenview Capital’s sector favorites include Thermo Fisher Scientific (TMO), HCA Holdings Inc (HCA) and Tenet Healthcare Corp (THC). Over the quarter, Glenview Capital significantly increased its bets on Thermo Fisher Scientific, Humana Inc (HUM), and Community Health Systems Inc (CYH).

Other top investors that lead the Top Healthcare, Pharma and Biotech Hedge Fund List include #2 OrbiMed Advisors and #3 PointState Capital. The largest investments for OrbiMed Advisors, which is run by Samuel Isaly, include Intercept Inc (ICPT), Gilead Sciences Inc (GILD), Biogen Idec Inc (BIIB) and Bristol-Myers Squibb (BMY). Over the quarter, Isaly’s firm entered and bought up large stakes in Eli Lilly & Co (LLY), Tornier N.V. (TRNX) and Tesaro, Inc. (TSRO). OribMed also significantly increased its exposure to Intercept Inc (ICPT) and Allergan Inc (AGN) over the quarter.

Ranking Methodology: The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund rankings are compiled on a quarterly basis using hedge fund firms’ overall U.S. equity assets under management. The list includes the top hedge funds that have more than 35% of their U.S. equity assets invested in U.S. listed Healthcare, Pharma & Biotech companies. To view the Top Healthcare, Pharma & Biotech Hedge Fund list in its entirety, please visit HedgeTracker’s Hedge Fund Portal.
For Detailed Investor Profiles on these Investors, click below:
Glenview Capital Management
OrbiMed Advisors
Partner Fund Management
PointState Capital
Visium Asset Management LLC
Related People: Anuj Malhotra*; Brian Grossman; Christopher Aristides; Christopher James; Jacob Gottlieb; Larry Robbins; Samuel Isaly; Sean Cullinan*; Stanley Druckenmiller*; Zach Schreiber (CEO)
Related Entities: Catalyst Investment Management ; PointState Capital LP; PointState Fund LP; PointState Holdings LLC; Visium Credit Opportunities Fund; Visium Global Fund; Visium Long Bias Fund LP; Caduceus Asia Partners LP; Caduceus Capital LP; Eaton Vance Worldwide Health Sciences; Finsbury Worldwide Pharmaceutical; GCM Little Arbor Institutional Partners; GCM Little Arbor Master; GCM Little Arbor Partners; Glenview Capital Master; Glenview Capital Partners; Glenview Institutional Partners; OrbiMed Associates; OrbiMed Capital; Partner Fund; Partner Healthcare Fund; Partner Principal Fund; Partner Technology Fund; PFM Meritage; Point State Capital; Visium Balanced Fund
Related Article Tags: Multi-Strategy, Long Short, Equity, Debt and Global Macro Hedge Fund News; Top Hedge Fund Portfolio Reports


More Recent Headlines

Regulatory reporting - key considerations for fund managers and service providers

A Very Special Shareholder Meeting at Allergan

Top Hedge Funds surge past $900 billion Mark for first time, powered by Millennium, DE Shaw, Icahn and Gotham

Assets for Top Technology, Media & Telecom hedge funds up $2.4B YTD; Lone Pine steals top spot from Coatue Capital

West Coast heats up as Top California Hedge Funds see assets jump 5.6 percent

Nine Chapters Capital, Sheffield Asset Management and GRT Capital claim top spots on the Top Mid-Sized Hedge Fund List

Touted Goldman Sachs Alumni Disappoint in Hedge Fund Start-ups, Except for Azentus Capital & Coatue Capital

Top Connecticut Hedge Funds hold steady with $171.8 billion in Assets

Assets surge by 10% for Top Emerging Hedge Fund Managers; PDT Partners, Corvex Management and Roystone Capital lead the way

Top 200 New York Hedge Funds up $26 billion; Oversee nearly $830 billion